Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GARY GERSHONY

Allopathic & Osteopathic Physicians Internal Medicine Interventional Cardiology

NPI
1821095134
CMS profile
82100
Location
CONCORD, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$687.53

11 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $687.53 11

By paying entity

PY2019 · entire year · sorted by reported total

Page 1 of 1; records 1–11 of 11 matching records. This page contains 11 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

GARY GERSHONY

NPI 1821095134 · CMS profile ID 82100

Allopathic & Osteopathic Physicians / Internal Medicine / Interventional Cardiology

CONCORD, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–11 of 11 matching records. This page contains 11 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1821095134?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
GARY GERSHONY, NPI 1821095134, CMS profile ID 82100. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–11 of 11 matching records. This page contains 11 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1821095134?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). GARY GERSHONY, NPI 1821095134, CMS profile ID 82100. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–11 of 11 matching records. This page contains 11 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1821095134?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
GARY GERSHONY, NPI 1821095134, CMS profile ID 82100, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–11 of 11 matching records. This page contains 11 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1821095134?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

11 matching records · $687.53 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 11 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–11 of 11.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Abbott Laboratories $23.2712/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 666956871 CMS
Abbott Laboratories $150.0010/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 667342747 CMS
Abbott Laboratories $52.8810/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 669190987 CMS
Siemens Medical Solutions USA, Inc. $80.1309/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 631936167 CMS
CathWorks, Inc. $142.4209/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 705659073 CMS
E.R. Squibb & Sons, L.L.C. $21.9208/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651427791 CMS
Edwards Lifesciences Corporation $108.8105/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700738849 CMS
Edwards Lifesciences Corporation $30.5705/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700738851 CMS
Edwards Lifesciences Corporation $18.2405/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700738853 CMS
Edwards Lifesciences Corporation $42.9205/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700738855 CMS
PFIZER INC. $16.3703/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672659785 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $687.53 11
PY2022 $20.95 1

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2022
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2022
Generated from
OP_DTL_GNRL_PGYR2022_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $155.63 1
PY2023 Principal investigator $650.63 5
PY2022 Principal investigator $4,928.24 14
PY2021 Principal investigator $22,935.59 29
PY2020 Principal investigator $87,672.93 39
PY2019 Principal investigator $43,201.85 29

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

29 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 CSL Behring $1,000.00 12/17/2021 Covered Recipient Teaching Hospital
John Muir Medical Center - Wc
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome No dispute reported 06/30/2026 819674843
Principal investigator 1 CSL Behring $50.00 12/08/2021 Covered Recipient Teaching Hospital
John Muir Medical Center - Wc
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome No dispute reported 06/30/2026 819674839
Principal investigator 1 CSL Behring $764.10 12/08/2021 Covered Recipient Teaching Hospital
John Muir Medical Center - Wc
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome No dispute reported 06/30/2026 819674841
Principal investigator 1 Abbott Laboratories $750.00 12/02/2021 Non-covered Recipient Entity
John Muir Health System
A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions. No dispute reported 06/30/2026 827582697
Principal investigator 1 CSL Behring $54.00 11/18/2021 Covered Recipient Teaching Hospital
John Muir Medical Center - Concord
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome No dispute reported 06/30/2026 819682803
Principal investigator 1 Abbott Laboratories $1,248.75 11/10/2021 Non-covered Recipient Entity
John Muir Health System
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO) No dispute reported 06/30/2026 827582741
Principal investigator 1 Abbott Laboratories $750.00 10/26/2021 Non-covered Recipient Entity
John Muir Health System
A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions. No dispute reported 06/30/2026 827582695
Principal investigator 1 CSL Behring $1,016.25 10/26/2021 Covered Recipient Teaching Hospital
John Muir Medical Center - Concord
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome No dispute reported 06/30/2026 819682807
Principal investigator 1 CSL Behring $267.30 09/15/2021 Covered Recipient Teaching Hospital
John Muir Medical Center - Wc
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome No dispute reported 06/30/2026 819674833
Principal investigator 1 CSL Behring $250.00 09/08/2021 Covered Recipient Teaching Hospital
John Muir Medical Center - Wc
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome No dispute reported 06/30/2026 819674831
Principal investigator 1 CSL Behring $750.00 09/03/2021 Covered Recipient Teaching Hospital
John Muir Medical Center - Wc
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome No dispute reported 06/30/2026 819674829
Principal investigator 1 CSL Behring $1,000.00 08/13/2021 Covered Recipient Teaching Hospital
John Muir Medical Center - Wc
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome No dispute reported 06/30/2026 819674827
Principal investigator 1 Abbott Laboratories $337.50 07/28/2021 Non-covered Recipient Entity
John Muir Health System
Portico Continued Access Protocol No dispute reported 06/30/2026 827582727
Principal investigator 1 Abbott Laboratories $662.50 07/28/2021 Non-covered Recipient Entity
John Muir Health System
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO) No dispute reported 06/30/2026 827582737
Principal investigator 1 CSL Behring $250.00 07/16/2021 Covered Recipient Teaching Hospital
John Muir Medical Center - Wc
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome No dispute reported 06/30/2026 819674825
Principal investigator 1 CSL Behring $250.00 06/23/2021 Covered Recipient Teaching Hospital
John Muir Medical Center - Concord
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome No dispute reported 06/30/2026 819682795
Principal investigator 1 CSL Behring $250.00 06/16/2021 Covered Recipient Teaching Hospital
John Muir Medical Center - Concord
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome No dispute reported 06/30/2026 819682773
Principal investigator 1 CSL Behring $1,000.00 06/16/2021 Covered Recipient Teaching Hospital
John Muir Medical Center - Concord
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome No dispute reported 06/30/2026 819682775
Principal investigator 1 CSL Behring $764.10 05/14/2021 Covered Recipient Teaching Hospital
John Muir Medical Center - Concord
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome No dispute reported 06/30/2026 819682763
Principal investigator 1 CSL Behring $50.00 05/14/2021 Covered Recipient Teaching Hospital
John Muir Medical Center - Concord
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome No dispute reported 06/30/2026 819682793
Principal investigator 1 Abbott Laboratories $1,301.25 05/12/2021 Non-covered Recipient Entity
John Muir Health System
Portico Continued Access Protocol No dispute reported 06/30/2026 827582729
Principal investigator 1 Abbott Laboratories $425.62 05/05/2021 Non-covered Recipient Entity
John Muir Health System
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO) No dispute reported 06/30/2026 827582739
Principal investigator 1 CSL Behring $539.60 04/27/2021 Covered Recipient Teaching Hospital
John Muir Medical Center - Concord
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome No dispute reported 06/30/2026 819682805
Principal investigator 1 CSL Behring $50.00 03/12/2021 Covered Recipient Teaching Hospital
John Muir Medical Center - Concord
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome No dispute reported 06/30/2026 819682735
Principal investigator 1 CSL Behring $2,712.60 03/12/2021 Covered Recipient Teaching Hospital
John Muir Medical Center - Concord
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome No dispute reported 06/30/2026 819682743
Principal investigator 1 CSL Behring $2,651.40 02/11/2021 Covered Recipient Teaching Hospital
John Muir Medical Center - Concord
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects With Acute Coronary Syndrome No dispute reported 06/30/2026 819682731
Principal investigator 1 Abbott Laboratories $1,380.00 02/04/2021 Non-covered Recipient Entity
John Muir Health System
A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions. No dispute reported 06/30/2026 827582691
Principal investigator 1 Abbott Laboratories $2,100.00 02/04/2021 Non-covered Recipient Entity
John Muir Health System
A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions. No dispute reported 06/30/2026 827582693
Principal investigator 1 Abbott Laboratories $310.62 01/20/2021 Non-covered Recipient Entity
John Muir Health System
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO) No dispute reported 06/30/2026 827582735